Dilip Shanghvi tops global rich list of drug makers
Dilip Shanghvi is the founder MD of Sun Pharmaceuticals.Dilip Shanghvi is India's third richest billionaire in may his gross was of $16.4 billion.About his education ,He is alumni of University of Culcutta and f J. J. Ajmera High School and Bhawanipur Education Society College. Now in august his net worth is of $17.2 billion.He is on consistent rise. He started Sun Pharmaceuticals in 1983. Initially his company started with Psychiatry products followed by Cardiology and gastroenterology segments.
But the phenomenal rise in his wealth is shocking for everyone.His wealth grew at rate of 37.1% or $4.7 billion and its $17.2 billion now. He is a multi venture person. But all these ventures are in the field of Health science and pharmaceutical research. He holds 64% shares in SunPharma , 67% holding in SunPharma advanced research, 4% in NATCO pharma and 18% in Bio Light Israeli life sciences.
In India SunPharma is the largest Chronic Prescription company in India.
In 2014 Sun Pharma acquired Ranbaxy. Ranbaxy was an Indian company which was acquired by an Japanese Pharmaceutical gaint named Daiichi Sankyo. But now Ranbaxy is acquired by Dilip Shanghvi's SunPharma. After this acquisition SunPharma is largest pharmaceutical company in India. Also SunPharma is largest Indian Pharmaceutical company in USA. Sunpharma is fifth largest specialty generic company globally now.
72% of Sunpharma sales are from outside markets.Out of this global turnover 54% comes from USA. SunPharma is also having a huge balance sheet tuning up to INR 10,000 Crores.Capture
SunPharma is doing excellent in stock market too.Sunpharma shares on an average trade at INR 767.Also SunPharma has submitted an update dated july 16 2014 stating that Sunpharma has acquired Pharmalucence.Pharmalucence is a USA based company and is leading in the feild of Radiopharmaceuticals and sterile injectables.Pharmalucence is a FDA approved for its two new indications reportedly some Sulfur Colloid product.This indication has use in locating the lymph nodes in Breast cancer and malignant melanoma patients.
Dilip Shanghvi is the founder MD of Sun Pharmaceuticals.Dilip Shanghvi is India's third richest billionaire in may his gross was of $16.4 billion.About his education ,He is alumni of University of Culcutta and f J. J. Ajmera High School and Bhawanipur Education Society College. Now in august his net worth is of $17.2 billion.He is on consistent rise. He started Sun Pharmaceuticals in 1983. Initially his company started with Psychiatry products followed by Cardiology and gastroenterology segments.
But the phenomenal rise in his wealth is shocking for everyone.His wealth grew at rate of 37.1% or $4.7 billion and its $17.2 billion now. He is a multi venture person. But all these ventures are in the field of Health science and pharmaceutical research. He holds 64% shares in SunPharma , 67% holding in SunPharma advanced research, 4% in NATCO pharma and 18% in Bio Light Israeli life sciences.
In India SunPharma is the largest Chronic Prescription company in India.
In 2014 Sun Pharma acquired Ranbaxy. Ranbaxy was an Indian company which was acquired by an Japanese Pharmaceutical gaint named Daiichi Sankyo. But now Ranbaxy is acquired by Dilip Shanghvi's SunPharma. After this acquisition SunPharma is largest pharmaceutical company in India. Also SunPharma is largest Indian Pharmaceutical company in USA. Sunpharma is fifth largest specialty generic company globally now.
72% of Sunpharma sales are from outside markets.Out of this global turnover 54% comes from USA. SunPharma is also having a huge balance sheet tuning up to INR 10,000 Crores.Capture
SunPharma is doing excellent in stock market too.Sunpharma shares on an average trade at INR 767.Also SunPharma has submitted an update dated july 16 2014 stating that Sunpharma has acquired Pharmalucence.Pharmalucence is a USA based company and is leading in the feild of Radiopharmaceuticals and sterile injectables.Pharmalucence is a FDA approved for its two new indications reportedly some Sulfur Colloid product.This indication has use in locating the lymph nodes in Breast cancer and malignant melanoma patients.
